{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"Research Square"}],"indexed":{"date-parts":[[2024,9,20]],"date-time":"2024-09-20T17:03:34Z","timestamp":1726851814888},"posted":{"date-parts":[[2023,10,9]]},"group-title":"In Review","reference-count":31,"publisher":"Research Square Platform LLC","license":[{"start":{"date-parts":[[2023,10,9]],"date-time":"2023-10-09T00:00:00Z","timestamp":1696809600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2023,9,26]]},"abstract":"<jats:title>Abstract<\/jats:title>\n        <jats:p>Background\n Diagnosis of malignant pleural effusion (MPE) is made by cytological examination of pleural fluid or histological examination of pleural tissue from biopsy. Unfortunately, detection of malignancy using cytology has an overall sensitivity of 50%, and is dependent upon tumor load, volume of fluid assessed, and cytopathologist experience. The diagnostic yield of pleural fluid cytology is also compromised by low abundance of tumor cells or when morphology is obscured by inflammation or reactive mesothelial cells. A reliable molecular marker that may complement fluid cytology malignant pleural effusion diagnosis is needed. The purpose of this study was to establish a molecular diagnostic approach based on pleural effusion cell-free DNA methylation analysis for the differential diagnosis of malignant pleural effusion and benign pleural effusion.\nResults\n This was a blind, prospective case-control biomarker study. We recruited 104 patients with pleural effusion for the study. We collected pleural fluid from patients with: MPE (n\u2009=\u200948), PPE (n\u2009=\u200928), and benign PE (n\u2009=\u200928), and performed the Sentinel-MPE liquid biopsy assay. The methylation level of Sentinel-MPE was markedly higher in the MPE samples compared to BPE control samples (p\u2009&lt;\u20090.0001) and the same tendency was observed relative to PPE (p\u2009=\u20090.004). We also noted that the methylation signal was significantly higher in PPE relative to BPE (p\u2009&lt;\u20090.001). We also assessed the diagnostic efficiency of the Sentinel-MPE test by performing receiver operating characteristic analysis (ROC). For the ROC analysis we combined the malignant and paramalignant groups (n\u2009=\u200976) and compared against the benign group (n\u2009=\u200928). The detection sensitivity and specificity of the Sentinel-MPE test was high (AUC\u2009=\u20090.912). The Sentinel-MPE appears to have better performance characteristics than cytology analysis. However, combining Sentinel-MPE with cytology analysis could be an even more effective approach for the diagnosis of MPE.\nConclusions\n The Sentinel-MPE test can discriminate between BPE and MPE. The Sentinel-MPE liquid biopsy test can detect aberrant DNA in several different tumor types. The Sentinel-MPE test can be a complementary tool to cytology in the diagnosis of MPE.<\/jats:p>","DOI":"10.21203\/rs.3.rs-3390107\/v1","type":"posted-content","created":{"date-parts":[[2023,10,9]],"date-time":"2023-10-09T21:00:44Z","timestamp":1696885244000},"source":"Crossref","is-referenced-by-count":1,"title":["Cell-Free DNA Methylation Analysis as a Marker of Malignancy in Pleural Fluid"],"prefix":"10.21203","author":[{"given":"Billie","family":"Bixby","sequence":"first","affiliation":[{"name":"University of Arizona"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lukas","family":"Vrba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jyoti","family":"Lenka","sequence":"additional","affiliation":[{"name":"University of Arizona"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc","family":"Oshiro","sequence":"additional","affiliation":[{"name":"University of Arizona"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George S.","family":"Watts","sequence":"additional","affiliation":[{"name":"University of Arizona"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Trina.","family":"Hughes","sequence":"additional","affiliation":[{"name":"University of Arizona"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heidi","family":"Erickson","sequence":"additional","affiliation":[{"name":"University of Arizona"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Madhav","family":"Chopra","sequence":"additional","affiliation":[{"name":"University of Arizona"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James L.","family":"Knepler","sequence":"additional","affiliation":[{"name":"University of Arizona"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenneth S","family":"Knox","sequence":"additional","affiliation":[{"name":"University of Arizona"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa","family":"Jarnagin","sequence":"additional","affiliation":[{"name":"University of Arizona"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raed","family":"Alalawi","sequence":"additional","affiliation":[{"name":"University of Arizona"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mrinalini","family":"Kala","sequence":"additional","affiliation":[{"name":"University of Arizona"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Bernert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joshua","family":"Routh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Denise J.","family":"Roe","sequence":"additional","affiliation":[{"name":"University of Arizona"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linda L.","family":"Garland","sequence":"additional","affiliation":[{"name":"University of Arizona"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernard W.","family":"Futscher","sequence":"additional","affiliation":[{"name":"University of Arizona"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark A.","family":"Nelson","sequence":"additional","affiliation":[{"name":"University of Arizona"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"8761","reference":[{"key":"ref1","first-page":"P11-2","article-title":"Malignant Pleural Effusions","volume":"194","author":"Semaan R","year":"2016","unstructured":"Semaan R, Feller-Kopman D, Slatore C, Sockrider M. Malignant Pleural Effusions. Am J Respir Crit Care Med 2016;194:P11-2.","journal-title":"Am J Respir Crit Care Med"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"106802","DOI":"10.1016\/j.rmed.2022.106802","article-title":"Update on the diagnosis and management of malignant pleural effusions","volume":"196","author":"Bashour SI","year":"2022","unstructured":"Bashour SI, Mankidy BJ, Lazarus DR. Update on the diagnosis and management of malignant pleural effusions. Respir Med 2022;196:106802.","journal-title":"Respir Med"},{"key":"ref3","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02018-2018","article-title":"Ultrasound elastography: a novel tool for the differential diagnosis of pleural effusion","volume":"54","author":"Jiang B","year":"2019","unstructured":"Jiang B, Li XL, Yin Y, et al. Ultrasound elastography: a novel tool for the differential diagnosis of pleural effusion. Eur Respir J 2019;54.","journal-title":"Eur Respir J"},{"key":"ref4","first-page":"377","article-title":"Pleural Effusion in Adults-Etiology, Diagnosis, and Treatment","volume":"116","author":"Jany B","year":"2019","unstructured":"Jany B, Welte T. Pleural Effusion in Adults-Etiology, Diagnosis, and Treatment. Dtsch Arztebl Int 2019;116:377\u201386.","journal-title":"Dtsch Arztebl Int"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1183\/09031936.97.10081907","article-title":"Pleural diseases related to metastatic malignancies","volume":"10","author":"Sahn SA","year":"1997","unstructured":"Sahn SA. Pleural diseases related to metastatic malignancies. Eur Respir J 1997;10:1907\u201313.","journal-title":"Eur Respir J"},{"key":"ref6","first-page":"55","article-title":"Malignant Pleural Effusion and Its Current Management: A Review","author":"Skok K","year":"2019","unstructured":"Skok K, Hladnik G, Grm A, Crnjac A. Malignant Pleural Effusion and Its Current Management: A Review. Medicina (Kaunas) 2019;55.","journal-title":"Medicina (Kaunas)"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.ccm.2017.11.004","article-title":"Malignant Pleural Effusion: From Diagnostics to Therapeutics","volume":"39","author":"Asciak R","year":"2018","unstructured":"Asciak R, Rahman NM. Malignant Pleural Effusion: From Diagnostics to Therapeutics. Clin Chest Med 2018;39:181\u201393.","journal-title":"Clin Chest Med"},{"issue":"Suppl 2","key":"ref8","doi-asserted-by":"crossref","first-page":"ii4-17","DOI":"10.1136\/thx.2010.136978","article-title":"Investigation of a unilateral pleural effusion in adults: British Thoracic Society Pleural Disease Guideline 2010","volume":"65","author":"Hooper C","year":"2010","unstructured":"Hooper C, Lee YC, Maskell N, Group BTSPG. Investigation of a unilateral pleural effusion in adults: British Thoracic Society Pleural Disease Guideline 2010. Thorax 2010;65 Suppl 2:ii4-17.","journal-title":"Thorax"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.disamonth.2012.11.002","article-title":"Pleural effusions","volume":"59","author":"Porcel JM","year":"2013","unstructured":"Porcel JM, Light RW. Pleural effusions. Dis Mon 2013;59:29\u201357.","journal-title":"Dis Mon"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S1525-1578(10)60583-1","article-title":"Microsatellite analysis of pleural supernatants could increase sensitivity of pleural fluid cytology","volume":"7","author":"Woenckhaus M","year":"2005","unstructured":"Woenckhaus M, Grepmeier U, Werner B, et al. Microsatellite analysis of pleural supernatants could increase sensitivity of pleural fluid cytology. J Mol Diagn 2005;7:517\u201324.","journal-title":"J Mol Diagn"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"e84225","DOI":"10.1371\/journal.pone.0084225","article-title":"Diagnostic and prognostic value of SHOX2 and SEPT9 DNA methylation and cytology in benign, paramalignant and malignant pleural effusions","volume":"8","author":"Dietrich D","year":"2013","unstructured":"Dietrich D, Jung M, Puetzer S, et al. Diagnostic and prognostic value of SHOX2 and SEPT9 DNA methylation and cytology in benign, paramalignant and malignant pleural effusions. PLoS One 2013;8:e84225.","journal-title":"PLoS One"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1038\/nrc3066","article-title":"Cell-free nucleic acids as biomarkers in cancer patients","volume":"11","author":"Schwarzenbach H","year":"2011","unstructured":"Schwarzenbach H, Hoon DS, Pantel K. Cell-free nucleic acids as biomarkers in cancer patients. Nat Rev Cancer 2011;11:426\u201337.","journal-title":"Nat Rev Cancer"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/nrc.2017.7","article-title":"Liquid biopsies come of age: towards implementation of circulating tumour DNA","volume":"17","author":"Wan JCM","year":"2017","unstructured":"Wan JCM, Massie C, Garcia-Corbacho J, et al. Liquid biopsies come of age: towards implementation of circulating tumour DNA. Nat Rev Cancer 2017;17:223\u201338.","journal-title":"Nat Rev Cancer"},{"key":"ref14","first-page":"646","article-title":"Free DNA in the serum of cancer patients and the effect of therapy","volume":"37","author":"Leon SA","year":"1977","unstructured":"Leon SA, Shapiro B, Sklaroff DM, Yaros MJ. Free DNA in the serum of cancer patients and the effect of therapy. Cancer Res 1977;37:646\u201350.","journal-title":"Cancer Res"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.cell.2015.11.050","article-title":"Cell-free DNA Comprises an In Vivo Nucleosome Footprint that Informs Its Tissues-Of-Origin","volume":"164","author":"Snyder MW","year":"2016","unstructured":"Snyder MW, Kircher M, Hill AJ, Daza RM, Shendure J. Cell-free DNA Comprises an In Vivo Nucleosome Footprint that Informs Its Tissues-Of-Origin. Cell 2016;164:57\u201368.","journal-title":"Cell"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"5068","DOI":"10.1038\/s41467-018-07466-6","article-title":"Comprehensive human cell-type methylation atlas reveals origins of circulating cell-free DNA in health and disease","volume":"9","author":"Moss J","year":"2018","unstructured":"Moss J, Magenheim J, Neiman D, et al. Comprehensive human cell-type methylation atlas reveals origins of circulating cell-free DNA in health and disease. Nat Commun 2018;9:5068.","journal-title":"Nat Commun"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"224ra24","DOI":"10.1126\/scitranslmed.3007094","article-title":"Detection of circulating tumor DNA in early- and late-stage human malignancies","volume":"6","author":"Bettegowda C","year":"2014","unstructured":"Bettegowda C, Sausen M, Leary RJ, et al. Detection of circulating tumor DNA in early- and late-stage human malignancies. Sci Transl Med 2014;6:224ra24.","journal-title":"Sci Transl Med"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"16368","DOI":"10.1073\/pnas.0507904102","article-title":"Detection and quantification of mutations in the plasma of patients with colorectal tumors","volume":"102","author":"Diehl F","year":"2005","unstructured":"Diehl F, Li M, Dressman D, et al. Detection and quantification of mutations in the plasma of patients with colorectal tumors. Proc Natl Acad Sci U S A 2005;102:16368\u201373.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref19","first-page":"1659","article-title":"DNA fragments in the blood plasma of cancer patients: quantitations and evidence for their origin from apoptotic and necrotic cells","volume":"61","author":"Jahr S","year":"2001","unstructured":"Jahr S, Hentze H, Englisch S, et al. DNA fragments in the blood plasma of cancer patients: quantitations and evidence for their origin from apoptotic and necrotic cells. Cancer Res 2001;61:1659\u201365.","journal-title":"Cancer Res"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1373\/clinchem.2011.171264","article-title":"Quantification of methylated markers with a multiplex methylation-specific technology","volume":"58","author":"Zou H","year":"2012","unstructured":"Zou H, Allawi H, Cao X, et al. Quantification of methylated markers with a multiplex methylation-specific technology. Clin Chem 2012;58:375\u201383.","journal-title":"Clin Chem"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"8616","DOI":"10.1158\/0008-5472.CAN-08-1419","article-title":"Agglomerative epigenetic aberrations are a common event in human breast cancer","volume":"68","author":"Novak P","year":"2008","unstructured":"Novak P, Jensen T, Oshiro MM, Watts GS, Kim CJ, Futscher BW. Agglomerative epigenetic aberrations are a common event in human breast cancer. Cancer Res 2008;68:8616\u201325.","journal-title":"Cancer Res"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1073\/pnas.0710735105","article-title":"High-resolution mapping of DNA hypermethylation and hypomethylation in lung cancer","volume":"105","author":"Rauch TA","year":"2008","unstructured":"Rauch TA, Zhong X, Wu X, et al. High-resolution mapping of DNA hypermethylation and hypomethylation in lung cancer. Proc Natl Acad Sci U S A 2008;105:252\u20137.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"e486","DOI":"10.1371\/journal.pmed.0030486","article-title":"A genome-wide screen for promoter methylation in lung cancer identifies novel methylation markers for multiple malignancies","volume":"3","author":"Shames DS","year":"2006","unstructured":"Shames DS, Girard L, Gao B, et al. A genome-wide screen for promoter methylation in lung cancer identifies novel methylation markers for multiple malignancies. PLoS Med 2006;3:e486.","journal-title":"PLoS Med"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"E32","DOI":"10.1093\/nar\/28.8.e32","article-title":"MethyLight: a high-throughput assay to measure DNA methylation","volume":"28","author":"Eads CA","year":"2000","unstructured":"Eads CA, Danenberg KD, Kawakami K, et al. MethyLight: a high-throughput assay to measure DNA methylation. Nucleic Acids Res 2000;28:E32.","journal-title":"Nucleic Acids Res"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1080\/15592294.2019.1695333","article-title":"DNA methylation biomarkers discovered in silico detect cancer in liquid biopsies from non-small cell lung cancer patients","volume":"15","author":"Vrba L","year":"2020","unstructured":"Vrba L, Oshiro MM, Kim SS, et al. DNA methylation biomarkers discovered in silico detect cancer in liquid biopsies from non-small cell lung cancer patients. Epigenetics 2020;15:419\u201330.","journal-title":"Epigenetics"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"e0232181","DOI":"10.1371\/journal.pone.0232181","article-title":"Microbiome profile associated with malignant pleural effusion","volume":"15","author":"Shojaee S","year":"2020","unstructured":"Shojaee S, Sharma A, Gottel N, Sanchez T, Gilbert JA, Rahman NM. Microbiome profile associated with malignant pleural effusion. PLoS One 2020;15:e0232181.","journal-title":"PLoS One"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1513\/AnnalsATS.201902-189CME","article-title":"Contemporary Approach to the Diagnosis of Malignant Pleural Effusion","volume":"16","author":"Kaul V","year":"2019","unstructured":"Kaul V, McCracken DJ, Rahman NM, Epelbaum O. Contemporary Approach to the Diagnosis of Malignant Pleural Effusion. Ann Am Thorac Soc 2019;16:1099\u2013106.","journal-title":"Ann Am Thorac Soc"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"967079","DOI":"10.3389\/fonc.2022.967079","article-title":"A detection panel of novel methylated DNA markers for malignant pleural effusion","volume":"12","author":"Liang C","year":"2022","unstructured":"Liang C, Liu N, Zhang Q, et al. A detection panel of novel methylated DNA markers for malignant pleural effusion. Front Oncol 2022;12:967079.","journal-title":"Front Oncol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"3585","DOI":"10.7150\/jca.21368","article-title":"DNA Methylation Analysis of the SHOX2 and RASSF1A Panel in Bronchoalveolar Lavage Fluid for Lung Cancer Diagnosis","volume":"8","author":"Zhang C","year":"2017","unstructured":"Zhang C, Yu W, Wang L, et al. DNA Methylation Analysis of the SHOX2 and RASSF1A Panel in Bronchoalveolar Lavage Fluid for Lung Cancer Diagnosis. J Cancer 2017;8:3585\u201391.","journal-title":"J Cancer"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.chest.2023.01.019","article-title":"High Yield of Pleural Cell-Free DNA for Diagnosis of Oncogenic Mutations in Lung Adenocarcinoma","volume":"164","author":"Mahmood K","year":"2023","unstructured":"Mahmood K, Jampani P, Clarke JM, et al. High Yield of Pleural Cell-Free DNA for Diagnosis of Oncogenic Mutations in Lung Adenocarcinoma. Chest 2023;164:252\u201361.","journal-title":"Chest"},{"key":"ref31","author":"Arora RD","unstructured":"Arora RD, Boster J. Malignant Pleural Effusion. StatPearls. Treasure Island (FL) ineligible companies. Disclosure: Joshua Boster declares no relevant financial relationships with ineligible companies.2023."}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/www.researchsquare.com\/article\/rs-3390107\/v1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.researchsquare.com\/article\/rs-3390107\/v1.html","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,21]],"date-time":"2023-10-21T08:15:30Z","timestamp":1697876130000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.researchsquare.com\/article\/rs-3390107\/v1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,9]]},"references-count":31,"URL":"https:\/\/doi.org\/10.21203\/rs.3.rs-3390107\/v1","relation":{},"subject":[],"published":{"date-parts":[[2023,10,9]]},"subtype":"preprint"}}